Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Trazodone Dosing and Administration

Dosing for Insomnia/Sleep Disorders

  • When used specifically for insomnia, lower doses (25-50 mg) are typically employed, according to Praxis Medical Insights, and the American Academy of Sleep Medicine recommends against using trazodone for sleep onset or maintenance insomnia in adults 1
  • Initial dose for insomnia: 25 mg per day, as recommended by the American family physician 2, 3
  • Maximum dose for insomnia: 200-400 mg per day in divided doses when used as a mood-stabilizing/antiagitation drug, as stated by the American family physician 2, 3

Monitoring and Safety Considerations

  • Trazodone should be used with caution in patients with premature ventricular contractions, as advised by the American family physician 2, 3, 4

Efficacy Considerations

  • A full therapeutic trial of trazodone requires at least 4-8 weeks, as recommended by the American family physician 4, 5, 6
  • Dosage increases of trazodone should use increments of initial dose every 5-7 days until therapeutic benefits or significant side effects become apparent, according to the American family physician 4, 5, 6
  • After 9 months of trazodone treatment, consider dosage reduction to reassess the need for medication, as suggested by the American family physician 4, 5, 6

Trazodone Titration and Dosage

Initial Dosing and Titration

  • The American Academy of Family Physicians recommends starting trazodone at 100 mg and increasing the dose by increments of the initial dose every 5-7 days until therapeutic benefits appear or significant side effects develop, with a target range of 150-300 mg for full antidepressant efficacy 7
  • Increase trazodone dose by 100 mg increments every 5-7 days based on the general principle that dosage increases should use increments of the initial dose, with a maximum dose of 200-400 mg per day when used for mood stabilization or antiagitation 7

Treatment Duration and Monitoring

  • Allow at least 4-8 weeks at the therapeutic dose before concluding treatment failure, according to the American Academy of Family Physicians 7
  • Use trazodone with caution in patients with premature ventricular contractions and monitor for orthostatic hypotension, particularly during initial titration 7

Discontinuation

  • When discontinuing trazodone, taper over 10-14 days to limit withdrawal symptoms, as recommended by the American Academy of Family Physicians 7
  • After 9 months of treatment, consider dosage reduction to reassess the need for continued medication, according to the American Academy of Family Physicians 7

Trazodone Dosing Frequency for Sleep Disorders and PTSD-Related Nightmares

Standard Dosing Frequency by Indication

  • The American Academy of Sleep Medicine supports once-daily dosing at bedtime for insomnia and sleep disorders, with a mean effective dose of 212 mg/day, as it is equally effective and preferred for sleep disorders 8, 9
  • For PTSD-related nightmares, once-daily dosing at bedtime is recommended, with a mean effective dose of 212 mg/day, according to the Journal of Clinical Sleep Medicine 8, 9

Common Pitfalls to Avoid

  • The American Academy of Sleep Medicine warns against overlooking the sedation profile of trazodone, as 60% of patients experience side effects, particularly daytime sedation or dizziness 8, 9
  • Monitoring for serious adverse effects, such as priapism, is crucial, as it occurred in 5 of 74 patients in one cohort, requiring treatment discontinuation 8, 9

REFERENCES

1

Trazodone for Insomnia Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

9

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018